Cystic fibrosis carrier. Z14.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM Z14.1 became effective on October 1, 2018. This is the American ICD-10-CM version of Z14.1 - other international versions of ICD-10 Z14.1 may differ.
CDKL5; code, if known, to identify associated manifestations, such as:; cortical blindness (H47.61-); global developmental delay (F88) ICD-10-CM Diagnosis Code E30.0 [convert to ICD-9-CM]
Result Code Result Code Name UofM Result LOINC 480533 Cystic Fibrosis Profile 480554 CF, Screen 21654-9 480533 Cystic Fibrosis Profile 511943 PDF 51969-4 480533 Cystic Fibrosis Profile 480556 Comment: 77202-0
F88 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM F88 became effective on October 1, 2019.
ICD-10 code Z13. 79 for Encounter for other screening for genetic and chromosomal anomalies is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10 code R62. 50 for Unspecified lack of expected normal physiological development in childhood is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-9-CM Diagnosis Code 315.9 : Unspecified delay in development.
Z13. 228 - Encounter for screening for other metabolic disorders | ICD-10-CM.
The term 'developmental delay' or 'global development delay' is used when a child takes longer to reach certain development milestones than other children their age. This might include learning to walk or talk, movement skills, learning new things and interacting with others socially and emotionally.
315.9 - Unspecified delay in development | ICD-10-CM.
Global developmental delay (GDD), sometimes referred to as global developmental disorder, is a neurodevelopmental diagnosis in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
Z13. 89 Encounter for screening for other disorder (when not listed elsewhere in the ICD-10 codes) – usually not necessary to report in addition to a well-child exam.
• When a child's progression through predictable developmental phases slows, stops, or reverses. •Symptoms include slower-than-normal development of motor, cognitive, social, and emotional skills.
Group 1CodeDescription80047Metabolic panel ionized ca80048Metabolic panel total ca80051Electrolyte panel80053Comprehen metabolic panel3 more rows•Nov 21, 2019
cystic fibrosis (CF), also called mucoviscidosis, formerly cystic fibrosis of the pancreas, an inherited metabolic disorder, the chief symptom of which is the production of a thick, sticky mucus that clogs the respiratory tract and the gastrointestinal tract.
82947 is included in the BMP code. You should be using 80048 for your BMP code and that it is it.
Cystic fibrosis (OMIM 602421) is a common genetic disorder resulting in chronic pulmonary and gastrointestinal/pancreatic disease. There is wide variability in clinical symptoms. CF is inherited in a recessive manner, which means that both parents must be carriers to have an affected child. When both parents are carriers, there is a 25% chance with each pregnancy that the child will be affected. Genetic counseling and CF molecular testing are recommended for the reproductive partners and at-risk family members of CF carriers.
This assay detects as many as 90% of cystic fibrosis carriers in the Caucasian population. Within other ethnic groups, there may be higher or lower detection efficiency. Includes the mutation profile currently recommended by the ACMG and the ACOG.